Medpace Holdings, Inc. (MEDP)
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia.
The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It also provides clinical development services to the biotechnology, pharmaceutical, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services.
The company also provides bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials.
Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.
|IPO Date||Aug 11, 2016|
|Industry||Life Sciences Tools & Services|
5375 Medpace Way
Cincinnati, Ohio 45227-1543
|Phone||513 579 9911|
|Fiscal Year||January - December|
|Reporting Currency||US Dollars|
|Dr. August James Troendle M.D.||Chairman and Chief Executive Officer|
|Jesse J. Geiger BBA, CPA||President|
|Susan E. Burwig||Executive Vice President of Operations|
|Stephen P. Ewald||Chief Compliance Officer, General Counsel and Corporate Secretary|
|Kevin M. Brady||Chief Financial Officer and Treasurer|
|Brandon Ebken||Chief Information Officer|
|Lauren Morris||Associate Director of Investors Relations|
|Todd Meyers||Vice President of Business Development and Marketing|
|Weimin Gai MS||Senior Vice President of Biometrics|
|Daniel O'Leary||Senior Vice President of Medical Department|